Answers are grounded in this paper and cite their sources.
BACKGROUND: Until 1 decade ago, absolute uterine infertility invariably prevented women from bearing their own biological child. A major causative factor is Mayer-Rokitansky-Küster-Hauser syndrome. However, uterus transplantation (UTx) has recently emerged as a successful treatment strategy, with >70 children being born to UTx recipients. This clinical situation represents a unique immunological scenario-namely the combined sensitization risk from solid organ transplantation and exposure to paternal alloantigens of the fetus. METHODS: Given the rarity of such cases, we assessed HLA sensitization in this context using a microbead-based assay (Luminex) with HLA screening as well as single-antigen beads in 7 UTx patients. RESULTS: We observed broad, strong IgG alloimmune responses in 3 UTx recipients, directed against both donor and paternal alloantigens. These responses primarily emerged and amplified after graft hysterectomy and withdrawal of immunosuppression, while intermittently also being evidenced before hysterectomy in 1 case. This contrasts with 4 women with transplants remaining in situ and on immunosuppressive treatment, who lack sensitization signs so far. CONCLUSIONS: These scarce preliminary data already suggest a relevant risk of broad sensitization in this unusual setting. UTx may therefore (1) represent a unique model for studying HLA sensitization under combined physiological and nonphysiological conditions, (2) warrant informing recipients about the risk of HLA alloimmunization, and (3) require further investigation to understand the implications and long-term consequences, demanding the generation of larger datasets.
No takes yet. Share an insight, caveat, or question.
Regnath et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: